Adagio Therapeutics Inc (ADGI)
4.64 +0.04 (+0.87%) 09/13/22 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Mon, Sep 12th, 2022
Results
download Want to compare other data? Select Fields| Symbol | ADGI | STOK | CTKB | ||
| Company | Adagio Therapeutics Inc | Stoke Therapeutics Inc | Cytek Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.62 | 9.52 | 3.84 | ||
| High | 4.74 | 9.58 | 3.84 | ||
| Low | 4.40 | 9.27 | 3.84 | ||
| Last | 4.64 | 9.26 | 3.83 | ||
| Change | +0.04 | -0.21 | -0.03 | ||
| % Change | +0.87% | -2.22% | -0.78% | ||
| Volume | 536,300 | 44,193 | 2,322 | ||
| 20-Day Average Volume | 740,320 | 898,626 | 739,210 | ||
| Previous Close | 4.60 | 9.47 | 3.86 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.47 | 7.67 | 3.73 | ||
| 20-Day Raw Stochastic | 77.39% | 88.90% | 68.67% | ||
| 20-Day Relative Strength | 58.02% | 59.28% | 43.84% | ||
| Weighted Alpha | -67.60 | -29.47 | -50.22 | ||
| Today's Opinion | 24% Buy | 56% Sell | 88% Sell | ||
| Previous Opinion | 24% Buy | 56% Sell | 88% Sell | ||
| Last Month's Opinion | 16% Sell | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.93% since 09/02/22 | +1.95% since 04/22/25 | +1.32% since 04/22/25 | ||
| Low | 4.40 on 09/12/22 | 9.30 on 04/29/25 | 3.72 on 04/25/25 | ||
| High | 4.82 on 09/07/22 | 9.91 on 04/25/25 | 4.05 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | +16.29% since 08/12/22 | +30.37% since 03/28/25 | -4.00% since 03/28/25 | ||
| Low | 3.75 on 08/16/22 | 5.35 on 04/09/25 | 3.27 on 04/09/25 | ||
| High | 4.90 on 08/22/22 | 9.91 on 04/25/25 | 4.10 on 04/02/25 | ||
| 3-Month | |||||
| %Chg | +56.76% since 06/10/22 | -10.56% since 01/29/25 | -32.51% since 01/29/25 | ||
| Low | 2.41 on 06/15/22 | 5.35 on 04/09/25 | 3.27 on 04/09/25 | ||
| High | 4.90 on 08/22/22 | 12.98 on 02/05/25 | 5.84 on 01/30/25 | ||
| 6-Month | |||||
| %Chg | -8.12% since 03/11/22 | -24.19% since 10/29/24 | -20.17% since 10/29/24 | ||
| Low | 2.41 on 06/15/22 | 5.35 on 04/09/25 | 3.27 on 04/09/25 | ||
| High | 6.14 on 03/30/22 | 14.72 on 11/14/24 | 7.63 on 11/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 504,976 | 517,034 | 494,454 | ||
| Shares Outstanding, K | 108,831 | 54,597 | 128,097 | ||
| Annual Sales | 0 | 36,560,000 | 200,450,000 | ||
| Annual Net Income | -226,790,000 | -88,980,000 | -6,020,000 | ||
| Last Quarter Sales | 0 | 22,610,000 | 57,480,000 | ||
| Last Quarter Net Income | -50,990,000 | -10,480,000 | 9,640,000 | ||
| 60-Month Beta | N/A | 1.09 | 1.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.47 on 08/15/22 | -0.18 on 03/18/25 | 0.07 on 02/27/25 | ||
| Latest Earnings Date | 09/19/22 | 05/05/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||